$14.620
+0.295 (+2.02%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
DRTS 相似圖表分析預測
Alphio's DRTS stock price prediction model matches the current Alpha Tau Medical Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.70 (+0.55%). The 1-week path is $14.27 (-2.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Alpha Tau Medical Ltd 股票嗎?
Alpha Tau Medical Ltd (DRTS) is a good buy right now, trading at $14.64 with a strong year-to-date change of +203.11%. The RSI is at 56.24, indicating a healthy momentum. Analyst price targets suggest a potential upside of 9% to 16% based on recent upgrades, with H.C. Wainwright targeting $16 and Barclays at $17. The main risk is the negative EPS trend, with a reported EPS of -0.50, reflecting ongoing losses, but the dual listing and FDA approvals could drive future growth.
DRTS 股價於 Thursday 收在 $14.62,此前上漲 +2.02%
Alpha Tau Medical Ltd (DRTS) last closed at $14.62, gaining +2.02%. These facts feed the 1-day and 1-week DRTS price prediction above.
預測驅動因素
Alpha Tau Medical Ltd(DRTS)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 DRTS 最接近的股票,依相似度排序。
DRTS 季節性分析
Historically the probability of a positive September return for DRTS is 55.56%. December offers the highest probability of a positive month at 93.02%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。